Methodology to screen and evaluate cost/survival of anticancer drugs in advanced/metastatic gastrointestinal cancers. Phase I randomized phase II trial of gemcitabine, erlotinib, and cixutumumab ...
Global Biopsy Forceps Market is expected to grow at a significant CAGR of 6.5% by 2022 as the scope and its applications are rising enormously across the globe. Biopsy Forceps may be reusable and ...
Biopsy of a colorectal cancer (CRC) is highly unlikely to "seed" another cancer when performed on nontumor sites during the same colonoscopy, according to a large retrospective study. A recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback